查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448487

心血管器材市场：趋势、机会与竞争分析

Cardiovascular Device Market: Trends, Opportunities and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球心血管设备市场预计将达到1,158亿美元，预计2024年至2030年复合年增长率为4.8%。市场成长的主要驱动力是微创手术需求的增加、医疗保健支出的增加以及老年人口的增加。

直接影响心血管设备产业动态的新兴趋势包括对可携式心臟监测设备的需求增加、经导管主动脉瓣置换术(TAVR) 的采用增加以及生物可吸收支架的使用增加。

本研究提供了到 2028 年的全球心血管设备市场规模和预测，按类型、设备和地区分类如下：

该市场中的一些心血管设备公司包括美敦力公共有限公司、波士顿科学公司、雅培实验室、爱德华兹生命科学公司和强生公司。

基于综合研究，Lucintel 预计结构心臟设备、电生理、心臟辅助设备、诊断和监测设备领域在预测期内将呈现高于平均值的成长。

CRM 领域预计仍将是全球心血管设备市场中最大的市场。心臟去颤器的使用量不断增加主要是因为成本效益和安全性，预计这将导致 CRM 市场的显着成长。

预计北美在预测期内仍将是最大的市场，这主要是由于该地区存在大量合格患者群，且先进治疗的采用率很高。

本报告的特点

  • 市场规模/估计： 市场规模/估计：以出货收益计算的全球心血管设备市场规模估计（百万美元）。
  • 趋势和预测分析：按细分市场和地区分類的市场趋势（2018-2023）和预测（2024-2030）。
  • 细分市场分析：按类型、设备和各种用途的金额和出货收益预测全球心血管设备市场规模。
  • 区域分析：按北美、欧洲、亚洲等主要地区分類的全球心血管设备市场细分。
  • 成长机会：分析心血管设备市场不同应用和地区的成长机会。
  • 策略分析：包括併购、新产品开发、全球心血管设备市场竞争格局等。
  • 基于波特五力模型的产业竞争实力分析。

本报告解决了以下关键问题：

  • Q.1. 按类型、设备和地区划分，全球心血管设备市场最有前景和高成长的机会是什么？
  • Q.2.哪些产品领域预计将以更快的速度成长？
  • Q.3.您认为哪些地区未来会出现更快的成长？
  • Q.4. 影响市场动态的关键因素是什么？心血管设备市场的市场驱动因素、挑战和商业风险是什么？
  • Q.5. 这个心血管设备市场的商业风险和竞争威胁是什么？
  • Q.6.心血管设备市场的新趋势是什么？
  • Q.7. 心血管设备市场的客户需求有何改变？
  • Q.8. 心血管设备市场有哪些新开拓？
  • Q.9. 心血管设备市场的主要企业有哪些？主要企业正在采取哪些策略倡议来发展业务？
  • Q.10. 这个心血管设备市场市场占有率哪些竞争产品？
  • Q.11.过去五年心血管设备市场发生了哪些併购？

目录

第一章执行摘要

第二章 市场背景及分类

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势和预测
  • 全球心血管设备市场趋势及预测
  • 按类型分類的全球心血管设备市场
    • 心律管理 (CRM)
    • 心臟介入装置
    • 週边血管装置
    • 心臟辅助装置
    • 结构性心臟装置
    • 心血管外科
    • 电生理学
    • 诊断和监测设备
  • 按设备分類的全球心血管设备市场
    • 心律调节器
    • 心臟去颤器
    • 支架
    • 心导管
    • 导管导引线
    • 心臟瓣膜
    • 心电图（ECG）
    • 心臟事件记录器
    • 其他的

第四章 区域市场趋势及预测分析

  • 全球心血管设备市场区域分布
  • 北美心血管设备市场
  • 欧洲心血管设备市场
  • 亚太心血管设备市场
  • 其他地区心血管设备市场

第五章 竞争分析

  • 产品系列分析
  • 市场占有率分析
  • 营运整合
  • 地理范围
  • 波特五力分析

第六章成本结构分析

  • 销货成本
  • 销售、一般及管理费用
  • EBITDA获利率

第七章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球心血管设备市场成长机会
    • 全球心血管设备市场成长机会（按设备）
    • 按地区分類的全球心血管设备市场成长机会
  • 全球心血管设备市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球心血管器材市场的产能
    • 全球心血管设备市场的併购和合资企业
    • 技术开发

第八章主要企业概况

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronic Public Limited Company
  • CR Bard, Inc.
  • Johnson & Johnson
  • St. Jude Medical Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
简介目录

The global cardiovascular device market is expected to reach an estimated $115.8 billion by 2030 and it is forecast to grow at a CAGR of 4.8% from 2024 to 2030. The major drivers for market growth are growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.

Emerging trends which have a direct impact on the dynamics of the cardiovascular device industry include increasing demand of portable heart monitoring devices, rising adoption of transcatheter aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable stents.

A total of 112 figures / charts and 84 tables are provided in this 197-page report to help in your business decisions. Sample figures with some insights are shown below.

The study includes the cardiovascular device market size and a forecast for the global cardiovascular device market through 2028, segmented by type, device, and region, as follows:

Cardiovascular Device Market by Type [Value ($ Million) from 2018 to 2030]:

  • Cardiac Rhythm Management
  • Interventional Cardiac Devices
  • Peripheral Vascular Devices
  • Cardiac Assist Devices
  • Structural Heart Devices
  • Cardiovascular Surgery
  • Electrophysiology
  • Diagnostic & Monitoring Devices

Cardiovascular Device Market by Device [Value ($ Million) from 2018 to 2030]:

  • Pacemaker
  • Defibrillator
  • Stent
  • Cardiac Catheter
  • Guidewire
  • Heart Valve
  • ECG
  • Event Monitor
  • Others

Cardiovascular Device Market by Region [Value ($ Million) from 2018 to 2030]:

  • North America
  • United States
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • India
  • ROW
  • Brazil

Cardiovascular device companies profiled in this market include Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major suppliers of cardiovascular devices.

On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.

Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.

North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.

Some of the features of this report:

  • Market size estimates: Global cardiovascular device market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis:Market trend (2018-2023) and forecast (2024-2030) by segments and region.
  • Segmentation analysis: Global cardiovascular device market size by various applications such as type, and device in terms of value and volume shipment.
  • Regional analysis: Global cardiovascular device market breakdown by key regions such as North America, Europe, and Asia & Rest of World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions of cardiovascular device market.
  • Strategic analysis:This includes M&A, new product development, and competitive landscape of global cardiovascular device market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report addresses the following key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for global cardiovascular device market by type, which includes cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices, by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which products segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this cardiovascular device market?
  • Q.5. What are the business risks and competitive threats in this cardiovascular device market?
  • Q.6. What are the emerging trends in this cardiovascular device market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the cardiovascular device market?
  • Q.8. What are the new developments in the cardiovascular device market and which companies are leading these developments?
  • Q.9. Who are the major players in this cardiovascular device market? What strategic initiatives are being taken by key companies for business growth?
  • Q.10. What are some of the competing products in this cardiovascular device market and how big of a threat do they pose for loss of market share by product substitution?
  • Q.11. What M&A activity has occurred in thecardiovascular device market during last 5 years?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Cardiovascular Device Market Trends and Forecast
  • 3.3: Global Cardiovascular Device Market by Type
    • 3.3.1: Cardiac Rhythm Management (CRM)
    • 3.3.2: Interventional Cardiac Devices
    • 3.3.3: Peripheral Vascular Devices
    • 3.3.4: Cardiac Assist Devices
    • 3.3.5: Structural Heart Devices
    • 3.3.6: Cardiovascular Surgery
    • 3.3.7: Electrophysiology
    • 3.3.8: Diagnostic & Monitoring Devices
  • 3.4: Global Cardiovascular Device Market by Device
    • 3.4.1: Pacemaker
    • 3.4.2: Defibrillator
    • 3.4.3: Stent
    • 3.4.4: Cardiac Catheter
    • 3.4.5: Guidewire
    • 3.4.6: Heart Valve
    • 3.4.7: Electrocardiogram (ECG)
    • 3.4.8: Event Monitor
    • 3.4.9: Others

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Cardiovascular Device Market by Region
  • 4.2: North American Cardiovascular Device Market
    • 4.2.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.2.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.2.3: The United States Cardiovascular Device Market
  • 4.3: European Cardiovascular Device Market
    • 4.3.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.3.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.3.3: Cardiovascular Device Market of Germany
    • 4.3.4: The French Cardiovascular Device Market
    • 4.3.5: Cardiovascular Device Market of the United Kingdom
    • 4.3.6: The Italian Cardiovascular Device Market
    • 4.3.7: The Spanish Cardiovascular Device Market
  • 4.4: APAC Cardiovascular Device Market
    • 4.4.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.4.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.4.3: Japanese Cardiovascular Device Market
    • 4.4.4: The Chinese Cardiovascular Device Market
    • 4.4.5: Indian Cardiovascular Device Market
  • 4.5: ROW Cardiovascular Device Market
    • 4.5.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.5.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.5.3: Brazilian Cardiovascular Device Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Cost Structure Analysis

  • 6.1: Cost of Goods Sold
  • 6.2: SG&A
  • 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

  • 7.1: Growth Opportunity Analysis
    • 7.1.1: Growth Opportunities for the Global Cardiovascular Device Market by Type
    • 7.1.2: Growth Opportunities for the Global Cardiovascular Device Market by Device
    • 7.1.3: Growth Opportunities for the Global Cardiovascular Device Market by Region
  • 7.2: Emerging Trends in the Global Cardiovascular Device Market
  • 7.3: Strategic Analysis
    • 7.3.1: New Product Development
    • 7.3.2: Capacity Expansion of the Global Cardiovascular Device Market
    • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiovascular Device Market
    • 7.3.4: Technology Development

8. Company Profiles of Leading Players

  • 8.1: Abbott Laboratories
  • 8.2: Boston Scientific Corporation
  • 8.3: Edwards Lifesciences Corporation
  • 8.4: Medtronic Public Limited Company
  • 8.5: C. R. Bard, Inc.
  • 8.6: Johnson & Johnson
  • 8.7: St. Jude Medical Inc.
  • 8.8: Cook Medical Inc.
  • 8.9: Terumo Corporation
  • 8.10: Cardinal Health Inc.